Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Vomiting 13Nausea 6Neoplasms 5Multiple Myeloma 2Breast Neoplasms 2Uterine Neoplasms 1Uterine Cervical Neoplasms 1Testicular Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Sarcoma 1Prevention of Nausea and Vomiting Caused by Highly Emetogenic Chemotherapy 1Ovarian Neoplasms 1Neoplasms, Germ Cell and Embryonal 1Nasopharyngeal Neoplasms 1Nasopharyngeal Carcinoma 1Melanoma 1Gynecologic Cancer 1Genital Neoplasms, Female 1Gastrointestinal Neoplasms 1Colorectal Neoplasms 1Carcinoma, Renal Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

Etoposide 30Carboplatin 30Cisplatin 23Ifosfamide 22Filgrastim 22Paclitaxel 18Peripheral Blood Stem Cell Transplantation 16Bleomycin 13Cyclophosphamide 11Radiotherapy 8Thiotepa 7Magnetic Resonance Spectroscopy 6Gemcitabine 6pegfilgrastim 5Therapeutics 5Melphalan 5Granulocyte Colony-Stimulating Factor 5Busulfan 5etoposide phosphate 4Temozolomide 4Oxaliplatin 4Dexamethasone 4sargramostim 3Vinblastine 3Taxes 3Psychiatric Rehabilitation 3Polymerase Chain Reaction 3Methylprednisolone 3Methods 3Immunohistochemistry 3

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Testicular Neoplasms × fosaprepitant × Clear all
NCT01736917 2016-05-25

Fosaprepitant + 5HT3 Receptor Antagonists + Dexamethasone in Germ Cell Tumors

Hoosier Cancer Research Network

Phase 2 Completed
65 enrolled 14 charts
Genitourinary

Neoplasms, Germ Cell and Embryonal, Testicular Neoplasms, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡